Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2018

  • ID: 4580427
  • Report
  • 67 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AngioDynamics Inc
  • C. R. Bard Inc
  • Guerbet LLC
  • Silmag SA
  • Tel Aviv University
  • MORE
Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Peripherally Inserted Central Catheter (PICC) - Medical Devices Pipeline Assessment, 2018" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AngioDynamics Inc
  • C. R. Bard Inc
  • Guerbet LLC
  • Silmag SA
  • Tel Aviv University
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Peripherally Inserted Central Catheter (PICC) Overview

3 Products under Development
3.1 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development
3.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory
3.3 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path
3.4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date

4 Peripherally Inserted Central Catheter (PICC) - Pipeline Products under Development by Companies
4.1 Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development
4.2 Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development

5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview
5.1 AngioDynamics Inc Company Overview
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 C. R. Bard Inc Company Overview
5.2.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Guerbet LLC Company Overview
5.3.1 Guerbet LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Silmag SA Company Overview
5.4.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 Tel Aviv University Company Overview
5.5.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.6 University of Texas Health Science Center at Houston Company Overview
5.6.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

6 Peripherally Inserted Central Catheter (PICC) - Recent Developments
6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.3 May 23, 2018: Access Scientific Completes Study Demonstrating Superior Anti-Thrombotic Properties of POWERWAND Midlines and Extended Dwell Catheters
6.4 May 17, 2018: Guerbet strengthens its leadership in innovative interventional radiology with the launch of two new microcatheters
6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.6 May 09, 2018: ICU Medical Announces First Quarter 2018 Results
6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.9 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.10 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.11 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
6.12 Mar 22, 2018: Access Scientific announces discovery of the cause of POWERWAND catheters’ ZERO bloodstream infections in over 35,000 catheter-days of published use
6.13 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results
6.14 Feb 22, 2018: Access Vascular Receives FDA Clearance for its HydroPICC Catheter
6.15 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
6.16 Feb 05, 2018: Zyno Solutions Names Steve Watkins As General Manager And Executive Vice President
6.17 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.18 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
6.19 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition
6.20 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.21 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.22 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results
6.23 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.24 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.25 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results
6.26 Oct 25, 2017: Bard Announces Third Quarter Results
6.27 Oct 24, 2017: POWERWAND Midline IV Catheter Achieves 23,000 Catheter Days with Zero Bloodstream Infections
6.28 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results
6.30 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California
6.31 Sep 14, 2017: Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
6.32 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.33 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results
6.34 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results
6.35 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
6.36 Jun 23, 2017: Vygon wins an international Business award for safe-enteral.com

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development
Table 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory
Table 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path
Table 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date
Table 5: Peripherally Inserted Central Catheter (PICC) Companies - Pipeline Products by Stage of Development
Table 6: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development
Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: BioFlo PICC Line Extension - Product Status
Table 9: BioFlo PICC Line Extension - Product Description
Table 10: Next Generation BioFlo PICC - Product Status
Table 11: Next Generation BioFlo PICC - Product Description
Table 12: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Anti-Thrombotic PICCs - Product Status
Table 14: Anti-Thrombotic PICCs - Product Description
Table 15: Antimicrobial PICC - Product Status
Table 16: Antimicrobial PICC - Product Description
Table 17: COVERT PowerPICC - Product Status
Table 18: COVERT PowerPICC - Product Description
Table 19: Guerbet LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: DraKon - Product Status
Table 21: DraKon - Product Description
Table 22: SeQure - Product Status
Table 23: SeQure - Product Description
Table 24: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
Table 25: PICC Intravenous Canalization Catheter - Product Status
Table 26: PICC Intravenous Canalization Catheter - Product Description
Table 27: PICC Percutaneous Catheter With Peel Off Introducer - Product Status
Table 28: PICC Percutaneous Catheter With Peel Off Introducer - Product Description
Table 29: PICC Percutaneous Catheter With Peel Off Introducer (Double Lumen) - Product Status
Table 30: PICC Percutaneous Catheter With Peel Off Introducer (Double Lumen) - Product Description
Table 31: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Short Peripheral Infusion Catheter - Product Status
Table 33: Short Peripheral Infusion Catheter - Product Description
Table 34: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Automated Catheter Insertion System - Product Status
Table 36: Automated Catheter Insertion System - Product Description
Table 37: Glossary

List of Figures
Figure 1: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Stage of Development
Figure 2: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Territory
Figure 3: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Regulatory Path
Figure 4: Peripherally Inserted Central Catheter (PICC) - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AngioDynamics Inc
  • C. R. Bard Inc
  • Guerbet LLC
  • Silmag SA
  • Tel Aviv University
  • University of Texas Health Science Center at Houston
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll